(Q51723788)

10 April 2018

title

Bleeding after antithrombotic therapy in patients with acute ischemic heart disease: is it the drugs or how we use them? (English)

1 reference

10 April 2018

main subject

coronary artery disease

1 reference

Marc Cohen

1

1 reference

10 April 2018

Karen P Alexander

series ordinal

2

1 reference

10 April 2018

Sunil V Rao

series ordinal

3

1 reference

10 April 2018

publication date

15 December 2007

1 reference

10 April 2018

Journal of Thrombosis and Thrombolysis

published in

1 reference

10 April 2018

volume

26

1 reference

10 April 2018

page(s)

175-182

1 reference

10 April 2018

issue

3

1 reference

10 April 2018

https://scigraph.springernature.com/pub.10.1007/s11239-007-0182-x

exact match

0 references

cites work

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11239-007-0182-X

Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11239-007-0182-X

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade.

21 January 2018

1 reference

12 December 2020

Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE).

1 reference

12 December 2020

Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes.

1 reference

12 December 2020

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update

1 reference

12 December 2020

Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial.

1 reference

12 December 2020

Fondaparinux versus enoxaparin in acute coronary syndromes

1 reference

12 December 2020

Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial

1 reference

12 December 2020

Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices.

1 reference

12 December 2020

Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial

1 reference

12 December 2020

Procedural volume as a marker of quality for CABG surgery.

1 reference

12 December 2020

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

12 December 2020

Comparison of fondaparinux and enoxaparin in acute coronary syndromes.

1 reference

12 December 2020

Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study

1 reference

12 December 2020

Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial

1 reference

12 December 2020

Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial

1 reference

12 December 2020

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

1 reference

12 December 2020

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

1 reference

12 December 2020

ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

1 reference

12 December 2020

Bivalirudin for patients with acute coronary syndromes

1 reference

12 December 2020

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.

1 reference

12 December 2020

Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction.

1 reference

12 December 2020

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

1 reference

12 December 2020

Adverse impact of bleeding on prognosis in patients with acute coronary syndromes.

1 reference

12 December 2020

Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes

1 reference

12 December 2020

Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative

1 reference

12 December 2020

Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes

1 reference

12 December 2020

Sex Differences in Major Bleeding With Glycoprotein IIb/IIIa Inhibitors

1 reference

12 December 2020

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

1 reference

12 December 2020

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

12 December 2020

A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes

1 reference

12 December 2020

Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention

1 reference

12 December 2020

10.1007/S11239-007-0182-X

Identifiers

DOI

1 reference

10 April 2018

PubMed ID

18080799

1 reference

10 April 2018